Allogen Biotech Limited
Summary
Allogen Biotech Limited was set up on Tuesday the 2nd of August 2011. Their current partial address is Dublin, and the company status is Normal. The company's current directors have been the director of 1 other Irish company between them; 1 of which is now closed. Allogen Biotech Limited has 21 shareholders. This Irish company shares its Eircode with at least 1 other company.
Company Vitals
- Company Name:Allogen Biotech Limited
- Time in Business:13 Years
- Company Number:501797
- Company Size:Micro Company
- Current Status:NORMAL
- Website:www.allogenbiotech.com
- Phone:+353 (0)1 685 3219
- Principal Activity:[73.10] Research and Experimental Development on Natural Sciences and Engineering
- May Trade As:Allogen Biotech Ltd
- Disclaimer: Other Details
- Please note the 'other details' displayed above are collected from a variety of public sources and are appended to this report for your convenience. As they are non-CRO data, we can not vouch for their accuracy or timeliness. To update contact details on this company simply email us
- Registered Address:12 Seafield Road,
Dublin 3,
Clontarf, Dublin
D03 YT25
€3
Directors
Purchase either the Standard Company Report or a Credit Report to view details on the directors of this company.
Judgments
Discover poor payment histories of any company by searching our Judgment Database, for court actions brought against a company for non-payment of a debt. Plus get free Judgment monitoring alerts on this company for the next 12 months.
Documents
| Document | Pages | Effective | Received | Buy |
|---|---|---|---|---|
| NEW! FINANCIAL STATEMENT | 17 | 31/10/2024 | 20/12/2024 | |
| NEW! Financial Statement Certificate | 1 | 31/10/2024 | 20/12/2024 | |
| NEW! Form B1C - Annual Return General | 9 | 31/10/2024 | 20/12/2024 | |
| FINANCIAL STATEMENT | 11 | 31/10/2023 | 21/12/2023 | |
| Financial Statement Certificate | 1 | 31/10/2023 | 21/12/2023 | |
| AMENDED CONSTITUTION | 36 | 13/12/2017 | 21/12/2017 | |
| Migrated Certificate | 2 | 02/08/2011 | 26/07/2011 |